Roschier represented Pareto Securities in Implantica AG’s IPO of Swedish Depository Receipts
Medtech company Implantica’s SEK 1,265 million Initial Public Offering of Swedish Depository Receipts on Nasdaq First North Premier Growth Market has been successfully completed. Pareto Securities acted as Global Coordinator and Sole Bookrunner in the IPO and Roschier acted as legal advisor to Pareto Securities.
Trading of the Swedish Depository Receipts on Nasdaq First North Premier Growth Market commenced on 21 September 2020.
Liechtenstein-based Implantica AG is a medtech group with operations within the implantable medical device and eHealth markets. The Company’s lead product RefluxStop™ is a passive CE-marked implant for prevention of gastroesophageal reflux.
Roschier’s advisory team comprises Pontus Enquist, Erik Persson and Miikka Kujanpää.